We deliver bespoke synthesis of HA polymers with precisely controlled N-acetylglucosamine (GlcNAc) linkage patterns, enabling tailored molecular weights and functional modifications for advanced biomedical applications.
There is no product in the shopping cart, buy it!
HAS is a pivotal Glycan Tool Enzyme responsible for the biosynthesis of hyaluronic acid (HA), a critical glycosaminoglycan with diverse biological functions. In the realm of N-acetyl-β-D-glucosamine-(1→4)-[HA] production service, This Glycosyltransferase plays a central role by catalyzing the sequential addition of N-acetylglucosamine and glucuronic acid units, forming the characteristic HA polymer. This enzymatic precision enables tailored synthesis of HA with specific molecular weights and structural modifications, ensuring optimal performance in biomedical, cosmetic, and pharmaceutical applications.
Are you currently facing challenges in achieving consistent molecular weight distributions, managing high-endotoxin levels in traditional Streptococcus cultures, or struggling with the metabolic burden of high-titer production? Our custom HAS production service helps you obtain high-quality HA synthases through our AI-driven design platform and advanced metabolic refactoring of microbial hosts. By optimizing precursor flux and stabilizing enzymatic transition states, Creative Biolabs accelerates your path from digital protein design to industrial-scale reality, ensuring your biopolymers meet the most stringent standards.
Fig.1 Custom HAS production process flow.1
Fig.2 Custom HAS production process flow.
Discover the Power of Our Assistance
Regulatory Compliance
"After migrating to the endotoxin-free B. subtilis expression system, our clinical-grade HA production achieved < 0.1 EU/mg endotoxin levels, meeting specific guidelines without additional purification steps."- 3 weeks ago, Prof. Sarah M***z.
Cost-Effective Scaling
"The engineered HAS variants provided by Creative Biolabs showed remarkable thermal stability in our one-pot synthesis trials, maintaining high activity even at elevated industrial temperatures."- 5 weeks ago, Prof. J***s K.
Custom HAS production enables the synthesis of ultra-pure, high-molecular-weight HA polymers tailored for controlled-release drug formulations. These polymers enhance bioavailability, reduce systemic toxicity, and improve targeted delivery of biologics, including monoclonal antibodies and gene therapies.
Engineered HAS variants produce HA polymers with precise molecular weights and crosslinking densities, ideal for 3D-printed scaffolds in tissue engineering. These materials support cell adhesion, proliferation, and differentiation for cartilage repair, bone regeneration, and wound healing applications.
The cosmetic industry leverages custom HAS to create HA derivatives with optimized skin penetration and moisture retention. Low-molecular-weight HA (LMW-HA) synthesized via targeted HAS mutations enhances transdermal absorption for anti-aging serums, while high-molecular-weight HA (HMW-HA) provides long-lasting hydration in fillers and creams.
Custom HAS-produced HA serves as a renewable alternative to petroleum-based polymers in eco-friendly packaging, biodegradable films, and hydrogel-based sensors. Its tunable rheological properties and water solubility make it ideal for food-grade coatings, agricultural mulch films, and even biodegradable lubricants, reducing environmental impact across industries.
Explore How We Can Meet Your Needs
A: Yes. By selecting and engineering specific HAS isoforms and controlling the fermentation duration and precursor concentration, we can target precise molecular weight ranges tailored to your application.
A: Because we primarily utilize organisms like Bacillus subtilis, our process is inherently lower in endotoxins compared to traditional Streptococcus methods, making it ideal for injectable grades.
A: Absolutely. For projects requiring absolute monodispersity and the highest purity, we can implement a one-pot multi-enzyme synthesis system with nucleotide sugar regeneration.
A: Lead times vary based on the complexity of the design, but typically range from 8 to 14 weeks from digital modeling to pilot-scale delivery. Contact us for a detailed project timeline.
A: Yes, Creative Biolabs provides comprehensive documentation, including batch records, purity analysis, and characterization data, to support your regulatory filings.
We deliver bespoke synthesis of HA polymers with precisely controlled N-acetylglucosamine (GlcNAc) linkage patterns, enabling tailored molecular weights and functional modifications for advanced biomedical applications.
Our expert team specializes in site-specific conjugation of carbohydrates to biologics, small molecules, or nanoparticles, enhancing stability, bioactivity, and targeted delivery for diagnostics and smart materials.
At Creative Biolabs, our custom HAS production service represents the pinnacle of modern bioprocessing. By combining AI-driven structural design with high-capacity industrial fermentation, we provide the precision and scale required to bring the next generation of biopolymers to market. For more information or to discuss your specific project requirements with our senior scientists, please reach out via our online portal.
Reference